The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 64-73

  Ströbel, Philipp ^a   Moritz, Regina ^b   Leite, Maria Isabel ^c   Willcox, Nick ^c   Chuang, Wen Yu ^d   Gold, Ralf ^e   Nix, Wilfred ^f   Schalke, Berthold ^g   Kiefer, Reinhard ^h   Müller Hermelink, Hans Konrad ⁱ   Jaretzki III, Alfred ^j   Newsom Davis, John ^k   Marx, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ UNIVERSITY OF WÜRZBURG   (Germany)

^j NewYork Presbyterian Hospital   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Ageing; Atrophy; Autoimmunity; Myasthenia gravis; Thymectomy; Thymus

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; PYRIDOSTIGMINE;

ADULT; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; LYMPHOID HYPERPLASIA; MALE; MORPHOMETRICS; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; THYMECTOMY; THYMOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGING; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MYASTHENIA GRAVIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SEX FACTORS; THYMECTOMY; THYMOMA; THYMUS EXTRACTS; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 51649105337     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.06.017     Document Type: Article

References (56)

1. Aarli J.A., Romi F., Skeie G.O., and Gilhus N.E. Myasthenia gravis in individuals over 40. Ann. N. Y. Acad. Sci. 998 (2003) 424-431
2. Ahmed S.A., Hissong B.D., Verthelyi D., Donner K., Becker K., and Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect. 107 Suppl 5 (1999) 681-686
3. Akashi K., Richie L.I., Miyamoto T., Carr W.H., and Weissman I.L. B lymphopoiesis in the thymus. J. Immunol. 164 (2000) 5221-5226
4. Alpert L.I., Papatestas A., Kark A., Osserman R.S., and Osserman K. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch. Pathol. 91 (1971) 55-61
5. Aspinall R., and Andrew D. Immunosenescence: potential causes and strategies for reversal. Biochem. Soc. Trans. 28 (2000) 250-254
6. Aspinall R., and Andrew D. Thymic involution in aging. J. Clin. Immunol. 20 (2000) 250-256
7. Bertho J.M., Demarquay C., Moulian N., Van Der Meeren A., Berrih-Aknin S., and Gourmelon P. Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life. Cell Immunol. 179 (1997) 30-40
8. Berzins S.P., Uldrich A.P., Sutherland J.S., Gill J., Miller J.F., Godfrey D.I., and Boyd R.L. Thymic regeneration: teaching an old immune system new tricks. Trends. Mol. Med. 8 (2002) 469-476
9. Blackburn C.C., Manley N.R., Palmer D.B., Boyd R.L., Anderson G., and Ritter M.A. One for all and all for one: thymic epithelial stem cells and regeneration. Trends Immunol. 23 (2002) 391-395
10. Bodey B., Bodey Jr. B., Siegel S.E., and Kaiser H.E. Involution of the mammalian thymus, one of the leading regulators of aging. In. Vivo. 11 (1997) 421-440
11. Buckley C., Newsom-Davis J., Willcox N., and Vincent A. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?. Neurology 57 (2001) 1579-1582
12. Christensson B., Biberfeld P., and Matell G. B-cell compartment in the thymus of patients with myasthenia gravis and control subjects. Ann. N. Y. Acad. Sci. 540 (1988) 293-297
13. Chuang W.Y., Strobel P., Gold R., Nix W., Schalke B., Kiefer R., Opitz A., Klinker E., Muller-Hermelink H.K., and Marx A. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann. Neurol. 58 (2005) 644-648
14. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M.B., Sullivan J.L., Jamieson B.D., Zack J.A., Picker L.J., and Koup R.A. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
15. Dunn-Walters D.K., Howe C.J., Isaacson P.G., and Spencer J. Location and sequence of rearranged immunoglobulin genes in human thymus. Eur. J. Immunol. 25 (1995) 513-519
16. Farrar J., Portolano S., Willcox N., Vincent A., Jacobson L., Newsom-Davis J., Rapoport B., and McLachlan S.M. Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int. Immunol. 9 (1997) 1311-1318
17. Ferone D., Pivonello R., Van Hagen P.M., Waaijers M., Zuijderwijk J., Colao A., Lombardi G., Bogers A.J., Lamberts S.W., and Hofland L.J. Age-related decrease of somatostatin receptor number in the normal human thymus. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E791-798
18. Franceschi C., Monti D., Barbieri D., Salvioli S., Grassilli E., Capri M., Troiano L., Guido M., Bonafe M., Tropea F., Salomoni P., Benatti F., Bellesia E., Macchioni S., Anderlini R., Sansoni P., Mariotti S., Wratten M.L., Tetta C., and Cossarizza A. Successful immunosenescence and the remodelling of immune responses with ageing. Nephrol Dial Transplant 11 Suppl 9 (1996) 18-25
19. Graus Y.F., de Baets M.H., van Breda Vriesman P.J., and Burton D.R. Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. Immunol. Lett. 57 (1997) 59-62
20. Harms H. Tissue image segmentation with multicolor, multifocal algorithms. In: Devijer P., and Kittler J. (Eds). Pattern Recognition Theory and Applications, NATO ASI Series F3 (1987), Springer, Berlin Heidelberg 519-528
21. Inaba M., Inaba K., Hosono M., Kumamoto T., Ishida T., Muramatsu S., Masuda T., and Ikehara S. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J. Exp. Med. 173 (1991) 549-559
22. Jaretzki III A., Penn A.S., Younger D.S., Wolff M., Olarte M.R., Lovelace R.E., and Rowland L.P. "Maximal" thymectomy for myasthenia gravis. Results. J. Thorac. Cardiovasc. Surg. 95 (1988) 747-757
23. Kawaguchi N., Kuwabara S., Nemoto Y., Fukutake T., Arimura K., Osame M., and Hattori T. Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin. Neurol. Neurosurg. 109 (2007) 858-861
24. Kirchner T., Schalke B., Melms A., von Kugelgen T., and Muller-Hermelink H.K. Immunohistological patterns of non-neoplastic changes in the thymus in myasthenia gravis. Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol. 52 (1986) 237-257
25. Laufer T.M., DeKoning J., Markowitz J.S., Lo D., and Glimcher L.H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383 (1996) 81-85
26. Leite M.I., Jones M., Strobel P., Marx A., Gold R., Niks E., Verschuuren J.J., Berrih-Aknin S., Scaravilli F., Canelhas A., Morgan B.P., Vincent A., and Willcox N. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am. J. Pathol. 171 (2007) 893-905
27. Levine G.D., and Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum. Pathol. 9 (1978) 495-515
28. Mackay I.R., Whittingham S., Goldstein G., Currie T.T., and Hare W.S. Myasthenia gravis: clinical, serological and histological studies in relation to thymectomy. Australas. Ann. Med. 17 (1968) 1-11
29. Marx A., Wilisch A., Schultz A., Gattenlohner S., Nenninger R., and Muller-Hermelink H.K. Pathogenesis of myasthenia gravis. Virchows Arch. 430 (1997) 355-364
30. Masaoka A., and Monden Y. Comparison of the results of transsternal simple, transcervical simple, and extended thymectomy. Ann. N. Y. Acad. Sci. 377 (1981) 755-765
31. Matthews I., Sims G., Ledwidge S., Stott D., Beeson D., Willcox N., and Vincent A. Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen. Lab. Invest. 82 (2002) 1407-1417
32. Meraouna A., Cizeron-Clairac G., Panse R.L., Bismuth J., Truffault F., Tallaksen C., and Berrih-Aknin S. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 108 (2006) 432-440
33. Muller-Hermelink H.K., and Marx A. Thymus. In: Damjanov I., and Lindner J. (Eds). Anderson's Pathology (1996), Mosby, St. Louis 1218-1243
34. Ohashi P.S. Immunology. Exposing thy self. Sci. 298 (2002) 1348-1349
35. Olanow C.W., Lane R.J., and Roses A.D. Thymectomy in late-onset myasthenia gravis. Arch. Neurol. 39 (1982) 82-83
36. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S., Mariani E., Mocchegiani E., and Solana R. T cells and aging, January 2002 update. Front. Biosci. 7 (2002) d1056-1183
37. Pescarmona E., Rosati S., Pisacane A., Rendina E.A., Venuta F., and Baroni C.D. Microscopic thymoma: histological evidence of multifocal cortical and medullary origin. Histopathology 20 (1992) 263-266
38. Pido-Lopez J., Imami N., and Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin. Exp. Immunol. 125 (2001) 409-413
39. Pizzighella S., Riviera A.P., and Tridente G. Thymic involvement in myasthenia gravis. Study by immunofluorescent and immunoperoxidase staining. J. Neuroimmunol. 4 (1983) 117-127
40. Remes-Troche J.M., Tellez-Zenteno J.F., Estanol B., Garduno-Espinoza J., and Garcia-Ramos G. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch. Med. Res. 33 (2002) 545-551
41. Rider V., Keltner S., and Abdou N.I. Increased estrogen-dependent expression of calcineurin in female SLE T cells is regulated by multiple mechanisms. J. Gend. Specif. Med. 6 (2003) 14-21
42. Romanyukha A.A., and Yashin A.I. Age related changes in population of peripheral T cells: towards a model of immunosenescence. Mech. Ageing Dev. 124 (2003) 433-443
43. Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., and Aarli J.A. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur. J. Neurol. 9 (2002) 55-61
44. Roxanis I., Micklem K., McConville J., Newsom-Davis J., and Willcox N. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis. J. Neuroimmunol. 125 (2002) 185-197
45. Simons R.J., and Reynolds H.Y. Altered immune status in the elderly. Semin. Respir. Infect. 5 (1990) 251-259
46. Sims G.P., Shiono H., Willcox N., and Stott D.I. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167 (2001) 1935-1944
47. Sonett J.G., and Jaretzki III A. Thymectomy for non-thymomatous MG - a critical analysis. Ann. N. Y. Acad. Sci. (2008) in press
48. Steinmann G.G., Klaus B., and Muller-Hermelink H.K. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J. Immunol. 22 (1985) 563-575
49. Strobel P., Helmreich M., Menioudakis G., Lewin S.R., Rudiger T., Bauer A., Hoffacker V., Gold R., Nix W., Schalke B., Elert O., Semik M., Muller-Hermelink H.K., and Marx A. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood 100 (2002) 159-166
50. Sund K.K., Skeie G.O., Gilhus N.E., Aarli J.A., and Varhaug J.E. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis]. Tidsskr Nor Laegeforen 117 (1997) 4212-4214
51. Touma M., Mori K.J., and Hosono M. Failure to remove autoreactive Vbeta6+ T cells in Mls-1 newborn mice attributed to the delayed development of B cells in the thymus. Immunology 100 (2000) 424-431
52. Vetshev P.S., Zairat'iants O.V., Ippolitov I., Belokrinitskii D.V., Shkrob L.O., Khodzhaev Z., and Kurochkin A.V. [Clinico-immunological features of generalized myasthenia in patients with hyperplasia and atrophy of the thymus gland]. Klin. Med. (Mosk) 69 (1991) 78-83
53. Willcox N., Schluep M., Ritter M.A., Schuurman H.J., Newsom-Davis J., and Christensson B. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?. Am. J. Pathol. 127 (1987) 447-460
54. Wolfe G.I., Kaminski H.J., Jaretzki III A., Swan A., and Newsom-Davis J. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy. Ann. N. Y. Acad. Sci. 998 (2003) 473-480
55. Yoneda S., Marx A., Heimann S., Shirakusa T., Kikuchi M., and Muller-Hermelink H.K. Low-grade metaplastic carcinoma of the thymus. Histopathology 35 (1999) 19-30
56. Zairat'iants O.V., Vetshev P.S., Ippolitov I., Shkrob L.O., Belokrinitskii D.V., Khodzhaev Z., and Radenska-Lopovok S.G. [The morphological and clinico-immunological characteristics of 2 types of myasthenia]. Arkh. Patol. 53 (1991) 22-27